HD-OPM Archive
Topics › Kidney health

CoQ10 trial in chronic kidney failure: 36% vs 90% needed dialysis

Louis Nervegna · Oct 16, 2026 · ♥ 18 reactions · 1 comments · original Facebook post
Kidney healthSupplements & vitamins
AI summary & key facts

The post highlights an older randomized, double-blind, placebo-controlled trial of coenzyme Q10 in chronic renal failure in which far fewer CoQ10 patients needed dialysis than placebo patients. The poster stresses he is not claiming CoQ10 reverses kidney disease, only that the research exists. The linked paper is from 2000, so confirmation in larger recent trials matters.

Link to journal paper:

Paper · Journal of Nutritional & Environmental Medicine · 2000Randomized, Double-blind Placebo-controlled Trial of Coenzyme Q10 in Chronic Renal Failure: Discovery of a New Roletandfonline.com

#coq10HD #kidneysHD

Research cited

A randomized double-blind placebo-controlled trial published in the journal Renal Failure found that only 36.2% of kidney patients taking CoQ10 required dialysis, compared to 90% in the placebo group.

That is a significant finding.

We are not saying CoQ10 reverses kidney disease.

We are saying the research exists, it has been replicated across multiple trials and populations, and most kidney patients have never been told it does.

Check the comment for the full breakdown of this study 👇

May be an image of medicine and text
← newer: Stanford experts say colonoscopy still matters despite a triolder: Stanford's Christopher Gardner on why seed oils are not the →